(Figure 5D)
It is important to emphasise that Ozempic is not currently licensed for insulin resistance in the absence of type 2 diabetes, nor for prediabetes, despite promising trial data
My background is in plastics and I have a love for nutrition because I am a total foodie
doi: 10.3389/fphar.2026.1754721 Received 26 November 2025 Revised 28 February 2026 Accepted 03 March 2026 Published 19 March 2026 Volume 17 - 2026 Edited by Achuthan Raghavamenon, Amala Cancer Research Centre, India Reviewed by Abdul Rahim Chethikkattuveli Salih, Terasaki Institute for Biomedical Innovation, United States Julio Plaza-Diaz, Childrens Hospital of Eastern Ontario (CHEO), Canada Updates Copyright 2026 Hu, Tian, Yang, Zhang, Zhang, Xu and Lu
Frustrated with weight loss programs that promise everything and deliver nothing